Welcome to our dedicated page for Genworth Finl SEC filings (Ticker: GNW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Genworth Financial, Inc. (NYSE: GNW) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including current reports, annual reports, and quarterly reports filed with the U.S. Securities and Exchange Commission. As a publicly traded holding company with operations in long-term care insurance, life and annuities, and U.S. mortgage insurance through Enact Holdings, Inc. (Nasdaq: ACT), Genworth uses these filings to present detailed financial and segment information.
Investors reviewing GNW SEC filings can examine how Genworth reports results for its Enact, Long-Term Care Insurance, and Life and Annuities segments, along with holding company activities. Filings such as Form 10-K and Form 10-Q typically include discussions of net income, adjusted operating income, segment performance, investment results, statutory capital measures, and risk-based capital ratios for U.S. life insurance subsidiaries. They also describe Genworth’s use of non-GAAP measures, including how adjusted operating income is defined and reconciled to GAAP net income.
Current reports on Form 8-K, such as the filing dated November 5, 2025, document material events including the release of quarterly financial results and the availability of related press releases and financial supplements. These filings often reference exhibits that contain detailed data tables and segment disclosures.
Through Stock Titan, users can follow GNW filings in real time as they are posted to the SEC’s EDGAR system. AI-powered tools summarize lengthy documents, highlight key themes such as capital allocation, share repurchase authorizations, segment trends, and legal or regulatory updates, and help clarify the implications of complex items like liability remeasurement in long-term care, reserve releases in mortgage insurance, or changes in market risk benefits. The filings page can also surface insider transaction reports on Form 4 and proxy-related disclosures when available, giving a fuller view of executive and governance-related information.
Genworth Financial executive vice president and general counsel Gregory S. Karawan reported equity award activity involving restricted stock units and common shares. On February 13, 2026, 21,892 restricted stock units were exercised and converted to 21,892 shares of common stock at a stated price of $0.00 per share, reflecting a vesting event rather than an open-market purchase.
To cover related tax withholding on the vested units, 6,076 common shares were withheld at $8.92 per share. After these transactions, Karawan directly owned 317,816 shares of Genworth common stock and also had an additional 4,731.743 shares held indirectly through a 401(k) plan.
Genworth Financial executive Mark Blakeley Hodges reported equity compensation activity involving restricted stock units and common shares. On February 13, 2026, 21,892 restricted stock units vested and were converted into 21,892 shares of common stock at no exercise price, increasing his direct holdings. The company then withheld 7,284 common shares, valued at $8.92 per share, to cover associated tax obligations. After these transactions, Hodges directly held 110,824 common shares, with an additional 4,526.476 shares held indirectly through a 401(k) plan.
Genworth Financial EVP and Chief HR Officer Melissa Hagerman reported equity compensation activity involving company stock. On February 13, 2026, 21,892 Restricted Stock Units were exercised and converted into 21,892 shares of common stock at $0.00 per share. To cover related tax withholding on the vested units, 7,184 common shares were disposed of at $8.92 per share. After these transactions, Hagerman directly owned 148,279 shares of Genworth Financial common stock.
Genworth Financial executive Jamala M. Arland, Pres. & CEO, U.S. Life Insurance, reported equity award activity. On February 13, 2026, 10,946 Restricted Stock Units vested and converted into 10,946 shares of Common Stock. The company then withheld 3,843 shares to cover tax obligations, leaving Arland with 48,010 shares of Common Stock held directly.
Donald Smith & Co., Inc. filed a Schedule 13G reporting beneficial ownership of 23,775,853 shares, or 5.95% of Genworth Financial Inc. common stock as of 12/31/2025. The filing is made on behalf of Donald Smith & Co., Inc. and DSCO Value Fund, L.P.
The shares are held for institutional clients in the ordinary course of business, not to change or influence control of Genworth. Donald Smith & Co., Inc. has sole voting power over 23,048,510 shares and sole dispositive power over 23,546,280 shares, with no shared voting or dispositive power reported.
Genworth Financial, Inc. filed a current report describing recent earnings-related announcements. Its publicly traded subsidiary, Enact Holdings, Inc. (Nasdaq: ACT), issued a press release with financial results for the quarter ended December 31, 2025, furnished as Exhibit 99.1.
Genworth also stated it will release its own earnings for the same quarter after the market closes on February 23, 2026, and will host a conference call on February 24, 2026 at 9:00 a.m. Eastern Time to discuss those results.
Genworth Financial Inc filed a Form 13F reporting institutional holdings with a total reported market value of $445,813,658. The report lists 2 information‑table entries and was signed by Darren W. Woodell, Vice President and Controller, on 01-23-2026.
Genworth Financial Inc. reported an insider stock transaction by its President and CEO, who is also a director. On December 2, 2025, the reporting person sold 40,000 shares of Genworth common stock at a price of $8.64 per share. After this sale, the reporting person beneficially owned 5,107,444 shares directly and 89,456 shares indirectly through trusts for the benefit of his children.
The filing notes that earlier in the year, on May 30, 2025, a grantor retained annuity trust (GRAT) terminated, resulting in 419,534 shares moving into the reporting person’s direct ownership and 89,456 shares being transferred to children’s trusts. The form also allows for the indication that the transaction may have been made under a pre-arranged Rule 10b5-1 trading plan.
Genworth Financial (GNW) insider plans Rule 144 sale after stock vesting. A holder has filed to sell 40,000 shares of GNW common stock through Fidelity Brokerage Services on the NYSE, with an indicated aggregate market value of $345,600. The filing shows that these shares were acquired on 03/03/2025 via restricted stock vesting from the issuer as compensation. As of the filing, 399,380,567 shares of GNW common stock were outstanding, providing context for the size of the planned sale.
Genworth Financial (GNW) executive David F. Kurzawa, EVP and General Counsel, reported a stock sale in a Form 4 filing. On 11/24/2025, he sold 40,000 shares of Genworth common stock at a weighted average price of $8.5101 per share through a series of broker-assisted transactions within a price range of $8.51 to $8.54 per share.
After this transaction, he beneficially owned 302,000 shares of Genworth common stock directly, plus 4,746.438 shares held indirectly through a 401(k) plan. The filing notes that detailed trade breakdowns within the reported price range are available upon request from the reporting person.